Literature DB >> 6972358

Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemic cells.

A W Burgess, D Metcalf.   

Abstract

Culture of WEHI-3B myelomonocytic leukemic cells in semi-solid agar medium containing serum from mice injected with endotoxin serum (ES) led to the development of maturing granulocytes and macrophages in most leukemic colonies. ES contains high levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), a regulator known to stimulate differentiation of these leukemic cells, but an antiserum which neutralized greater than 85% of the GM-CSF in ES did not suppress the differentiation-inducing activity of ES on WEHI-3B cells. The active factor in endotoxin serum stimulating differentiation in WEHI-3B leukemic cells (GM-DF) was separated from most of the GM-CSF by gel filtration using Ultrogel AcA44. The residual CSF associated with the GM-DF appeared to stimulate selectively granulocytic colonies. Disproportionation of GM-DF and GM-CSF was observed in ES fractions obtained using concanavalin-A/Sepharose chromatography: none of the GM-DF bound to this matrix, whereas 40% of the GM-CSF bound and was eluted with competing alpha methylglucopyranoside. Although no separation of GM-CSF and GM-DF was obtained using DEAE-Sepharose, non-isoelectric focusing in amphoteric buffers indicated charge differences between the differentiation factor and several sub-species of GM-CSF. Sequential purification of GM-DF from ES using 40 - 70% ammonium sulfate precipitation gel filtration and phenyl-Sepharose chromatography resulted in a 25-fold purification. In all fractionation procedures used, a sub-species of GM-CSF, stimulating granulocyte colony formation, was consistently associated with partially purified GM-DF, but some subspecies of GM-CSF clearly lacked any capacity to induce differentiation in the leukemic cells. The observations suggest that the factor in post-endotoxin serum most efficient in enforcing differentiation in myelomonocytic leukemic cells may be a subset of GM-CSF molecules with a selective capacity to stimulate granulocyte colony formation by normal cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6972358     DOI: 10.1002/ijc.2910260517

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

Review 1.  The discovery, development and clinical applications of granulocyte colony-stimulating factor.

Authors:  D C Dale
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

Review 2.  A (selective) history of Australian involvement in cytokine biology.

Authors:  Nicos A Nicola
Journal:  Cytokine Growth Factor Rev       Date:  2013-03-30       Impact factor: 7.638

3.  Localization of the human G-CSF gene to the region of a breakpoint in the translocation typical of acute promyelocytic leukemia.

Authors:  R N Simmers; J Smith; M F Shannon; G Wong; A F Lopez; E Baker; G R Sutherland; M A Vadas
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

4.  The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis.

Authors:  Armin Schneider; Carola Krüger; Tobias Steigleder; Daniela Weber; Claudia Pitzer; Rico Laage; Jaroslaw Aronowski; Martin H Maurer; Nikolaus Gassler; Walter Mier; Martin Hasselblatt; Rainer Kollmar; Stefan Schwab; Clemens Sommer; Alfred Bach; Hans-Georg Kuhn; Wolf-Rüdiger Schäbitz
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

5.  Identification of a signal-transduction pathway shared by haematopoietic growth factors with diverse biological specificity.

Authors:  S W Evans; D Rennick; W L Farrar
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

6.  Induced differentiation of avian myeloblastosis virus-transformed myeloblasts: phenotypic alteration without altered expression of the viral oncogene.

Authors:  G Symonds; K H Klempnauer; G I Evan; J M Bishop
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

7.  Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells.

Authors:  L R Rohrschneider; D Metcalf
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

8.  Time-dependent effect of combination therapy with erythropoietin and granulocyte colony-stimulating factor in a mouse model of hypoxic-ischemic brain injury.

Authors:  Ji Hea Yu; Jung Hwa Seo; Jong Eun Lee; Ji Hoe Heo; Sung-Rae Cho
Journal:  Neurosci Bull       Date:  2014-01-16       Impact factor: 5.203

9.  Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies.

Authors:  Jens Minnerup; Sevgi Sevimli; Wolf-Rüdiger Schäbitz
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

10.  Mechanisms that uncouple growth and differentiation in myeloid leukemia cells: restoration of requirement for normal growth-inducing protein without restoring induction of differentiation-inducing protein.

Authors:  J Lotem; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.